For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...

Eli Lilly, a renowned drug manufacturer, stated that its GLP-1 pill, orforglipron, assisted individuals in reducing 12.4% of their weight following 72 weeks in a late-stage study.The company ...

Eli Lilly shares plunged 12% in morning trading Thursday after reporting less-than-stellar results of a new study of an experimental anti-obesity pill that is expected to become a blockbuster.The pill ...

Live Updates Live Coverage Updates appear automatically as they are published. Discovery-ing Some Profits 9:40 am Continuing ...

Lilly said it will seek approval by international regulators ... slows the digestion of food and can reduce appetite. The ...